Randal G. Ross
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Randal G. Ross has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
Allen Radant
Seattle Veterans Administration Medical Center, USA
7 shared publicationsAnn Olincy
Department of Psychiatry, Denver Veterans' Administration Medical Center, Denver, Colorado, USA
4 shared publicationsRobert Freedman
Department of Psychiatry, Denver Veterans' Administration Medical Center, Denver, Colorado, USA
4 shared publicationsShari Heinlein
4 shared publicationsJosette G. Harris
Department of Psychiatry, The University of Colorado Health Sciences Center, Denver, Colorado, USA
3 shared publicationsLawrence E. Adler
Department of Psychiatry, University of Colorado Health Sciences Center, Denver, Colorado; Department of Psychiatry, Denver Veterans' Administration Medical Center, Denver, Colorado
3 shared publications
Latest Publications
- 27 October 2007
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 34 (1) , 47-51
The Stability of Inhibitory and Working Memory Deficits in Children and Adolescents Who are Children of Parents With Schizophrenia
Cognitive deficits are a central feature of schizophrenia and occur in first-degree relatives of schizophrenic probands, even in the absence of psychotic symptoms. A number of cognitive domains have been implicated including measures of response inhibition and working memory. While the stability of cognitive deficits has been demonstrated in individuals with schizophrenia, stability of deficits has not been explored in first-degree relatives. This report focuses on 25 children (ages 6-15 years), all with at least one schizophrenic parent. The children were assessed twice, utilizing inhibitory and working memory tasks, with a mean 2.6 years between visits. Stop reaction time (a measure of motor inhibition) and performance on a counting span task (a measure of verbal working memory) were borderline to mildly impaired (compared with a typically developing comparison group) at both visits with similar effect sizes (stopping task time 1, effect size = 0.46, time 2 effect size = 0.50; counting span time 1 effect size = 0.53, time 2 effect size = 0.42). For these 2 tasks, individual age-adjusted scores also correlated across both time points (r = 0.41-0.76) suggesting that individual children maintained deficits across time. As etiologically driven strategies are developed for the cognitive deficits of schizophrenia, expansion of these treatments to relatives who share the cognitive but not the psychotic symptoms may be worth exploring.
- 27 October 2007
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 34 (1) , 47-51
The Stability of Inhibitory and Working Memory Deficits in Children and Adolescents Who are Children of Parents With Schizophrenia
Cognitive deficits are a central feature of schizophrenia and occur in first-degree relatives of schizophrenic probands, even in the absence of psychotic symptoms. A number of cognitive domains have been implicated including measures of response inhibition and working memory. While the stability of cognitive deficits has been demonstrated in individuals with schizophrenia, stability of deficits has not been explored in first-degree relatives. This report focuses on 25 children (ages 6-15 years), all with at least one schizophrenic parent. The children were assessed twice, utilizing inhibitory and working memory tasks, with a mean 2.6 years between visits. Stop reaction time (a measure of motor inhibition) and performance on a counting span task (a measure of verbal working memory) were borderline to mildly impaired (compared with a typically developing comparison group) at both visits with similar effect sizes (stopping task time 1, effect size = 0.46, time 2 effect size = 0.50; counting span time 1 effect size = 0.53, time 2 effect size = 0.42). For these 2 tasks, individual age-adjusted scores also correlated across both time points (r = 0.41-0.76) suggesting that individual children maintained deficits across time. As etiologically driven strategies are developed for the cognitive deficits of schizophrenia, expansion of these treatments to relatives who share the cognitive but not the psychotic symptoms may be worth exploring.
- 1 December 2006
- Published by Elsevier in Schizophrenia Research
- Vol. 88 (1-3) , 90-95
High rates of comorbidity are found in childhood-onset schizophrenia
- 1 December 2006
- Published by Elsevier in Schizophrenia Research
- Vol. 88 (1-3) , 90-95
High rates of comorbidity are found in childhood-onset schizophrenia
- 1 July 2006
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 163 (7) , 1149-1152
Psychotic and Manic-like Symptoms During Stimulant Treatment of Attention Deficit Hyperactivity Disorder
- 1 July 2006
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 163 (7) , 1149-1152
Psychotic and Manic-like Symptoms During Stimulant Treatment of Attention Deficit Hyperactivity Disorder
- 23 June 2005
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 46 (12) , 1354-1362
Saccadic eye movement task identifies cognitive deficits in children with schizophrenia, but not in unaffected child relatives
Background: The delayed oculomotor response (DOR) task requires response inhibition followed by movement of gaze towards a known spatial location without a current stimulus. Abnormalities in response inhibition and in the spatial accuracy of the eye movement are found in individuals with schizophrenia and in many of their relatives, supporting the use of these saccadic abnormalities as endophenotypes in genetic studies. It is unknown whether school‐age children, either with psychosis or as relatives of a schizophrenic proband, can be included. Method: One hundred eighty‐seven children, ages 5.8–16.0 years – 45 children with childhood‐onset schizophrenia, 64 children with a first‐degree relative with schizophrenia, and 84 typically developing children – completed DOR tasks with 1 and 3 second delays. Results: Children with childhood‐onset schizophrenia demonstrated impaired response inhibition and impaired spatial accuracy compared to both relatives and typicals; however, relatives and typicals did not differ from each other. Conclusions: Children with childhood‐onset schizophrenia have saccadic abnormalities similar to those found in adults with schizophrenia, supporting the continuity of executive function deficits in childhood‐onset with adolescent and adult‐onset schizophrenia. However, saccadic tasks are not sensitive to genetic risk in non‐psychotic children and 6–15‐year‐old children should not be included in genetic studies utilizing this endophenotype.
- 23 June 2005
- Published by Wiley in Journal of Child Psychology and Psychiatry
- Vol. 46 (12) , 1354-1362
Saccadic eye movement task identifies cognitive deficits in children with schizophrenia, but not in unaffected child relatives
Background: The delayed oculomotor response (DOR) task requires response inhibition followed by movement of gaze towards a known spatial location without a current stimulus. Abnormalities in response inhibition and in the spatial accuracy of the eye movement are found in individuals with schizophrenia and in many of their relatives, supporting the use of these saccadic abnormalities as endophenotypes in genetic studies. It is unknown whether school‐age children, either with psychosis or as relatives of a schizophrenic proband, can be included. Method: One hundred eighty‐seven children, ages 5.8–16.0 years – 45 children with childhood‐onset schizophrenia, 64 children with a first‐degree relative with schizophrenia, and 84 typically developing children – completed DOR tasks with 1 and 3 second delays. Results: Children with childhood‐onset schizophrenia demonstrated impaired response inhibition and impaired spatial accuracy compared to both relatives and typicals; however, relatives and typicals did not differ from each other. Conclusions: Children with childhood‐onset schizophrenia have saccadic abnormalities similar to those found in adults with schizophrenia, supporting the continuity of executive function deficits in childhood‐onset with adolescent and adult‐onset schizophrenia. However, saccadic tasks are not sensitive to genetic risk in non‐psychotic children and 6–15‐year‐old children should not be included in genetic studies utilizing this endophenotype.
- 1 September 2003
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 13 (3) , 301-309
A 1-Year Open-Label Trial of Olanzapine in School-Age Children with Schizophrenia
Objective: To determine the response of children with childhood-onset schizophrenia to a 1-year prospective, open-label trial of olanzapine. Methods: Twenty children (age range 6-15 years) with childhood-onset Diagnostic and Statistical Manual of Mental Disorders (fourth edition) schizophrenia participated. The treating clinician was free to vary or discontinue dosing and use additional medications. Symptoms were assessed by the Brief Psychiatric Rating Scale-Child version (BPRS-C), Scale for the Assessment of Positive Symptoms, and Scale for the Assessment of Negative Symptoms. Extrapyramidal symptoms, akathisia, temperature, and weight were monitored. Results: BPRS-C subscales of thought disturbance and psychomotor excitation, and the Scale for the Assessment of Positive Symptoms demonstrated significant decreases by 6 weeks of treatment; BPRS-C anxiety and the Scale for the Assessment of Negative Symptoms (SANS) showed significant improvement after 1 year of treatment. Seventy-four percent of subjects were considered treatment responders, with a greater than 20% reduction in total BPRS-C score and overall impairment of mild or better. Weight gain (body mass index) was above that expected for normal development in every child. No child developed neuroleptic-related dyskinesias. Seventy-four percent (n = 14) of patients completed this 1-year, open-label trial. Of the 5 subjects who discontinued, weight gain was noted as the reason for 4 subjects. Conclusions: Olanzapine appears useful in the treatment of childhood-onset schizophrenia, although there may be a delayed onset of benefit for anxiety and negative symptoms. Weight gain is problematic, but the emergence of dyskinesias may be rare. Additional controlled trials are indicated.
- 1 September 2003
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 13 (3) , 301-309
A 1-Year Open-Label Trial of Olanzapine in School-Age Children with Schizophrenia
Objective: To determine the response of children with childhood-onset schizophrenia to a 1-year prospective, open-label trial of olanzapine. Methods: Twenty children (age range 6-15 years) with childhood-onset Diagnostic and Statistical Manual of Mental Disorders (fourth edition) schizophrenia participated. The treating clinician was free to vary or discontinue dosing and use additional medications. Symptoms were assessed by the Brief Psychiatric Rating Scale-Child version (BPRS-C), Scale for the Assessment of Positive Symptoms, and Scale for the Assessment of Negative Symptoms. Extrapyramidal symptoms, akathisia, temperature, and weight were monitored. Results: BPRS-C subscales of thought disturbance and psychomotor excitation, and the Scale for the Assessment of Positive Symptoms demonstrated significant decreases by 6 weeks of treatment; BPRS-C anxiety and the Scale for the Assessment of Negative Symptoms (SANS) showed significant improvement after 1 year of treatment. Seventy-four percent of subjects were considered treatment responders, with a greater than 20% reduction in total BPRS-C score and overall impairment of mild or better. Weight gain (body mass index) was above that expected for normal development in every child. No child developed neuroleptic-related dyskinesias. Seventy-four percent (n = 14) of patients completed this 1-year, open-label trial. Of the 5 subjects who discontinued, weight gain was noted as the reason for 4 subjects. Conclusions: Olanzapine appears useful in the treatment of childhood-onset schizophrenia, although there may be a delayed onset of benefit for anxiety and negative symptoms. Weight gain is problematic, but the emergence of dyskinesias may be rare. Additional controlled trials are indicated.
- Open Access
- 1 January 2003
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 29 (4) , 729-735
Creating School-Age Versions of Semistructured Interviews for the Prodrome to Schizophrenia: Lessons From Case Reviews
There is an increasing emphasis on identifying individuals with schizophrenia earlier and earlier in their disease process, with the assumption that earlier identification translates into earlier treatment, which translates into improved outcome. Unfortunately, one age cohort, children under 13 years of age, have been excluded from this critical alteration in clinical inter-vention strategy, and its associated improved clinical outcome. One of the barriers to inclusion of younger children is the lack of knowledge about diagnostic issues related to attenuated psychotic symptoms in this age sample. This report focuses on our experience with evaluating attenuated psychotic symptoms in young children, in particular subthreshold hallucinations and delusions, using semistructured interviews. The inclusion of both Caregiver and Child report sections and the addition of concrete, detailed examples of clear-conscience, non-stress-related subthreshold psychotic symptoms are likely to be necessary.
- 1 January 2003
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 29 (4) , 729-735
Open AccessCreating School-Age Versions of Semistructured Interviews for the Prodrome to Schizophrenia: Lessons From Case Reviews
There is an increasing emphasis on identifying individuals with schizophrenia earlier and earlier in their disease process, with the assumption that earlier identification translates into earlier treatment, which translates into improved outcome. Unfortunately, one age cohort, children under 13 years of age, have been excluded from this critical alteration in clinical inter-vention strategy, and its associated improved clinical outcome. One of the barriers to inclusion of younger children is the lack of knowledge about diagnostic issues related to attenuated psychotic symptoms in this age sample. This report focuses on our experience with evaluating attenuated psychotic symptoms in young children, in particular subthreshold hallucinations and delusions, using semistructured interviews. The inclusion of both Caregiver and Child report sections and the addition of concrete, detailed examples of clear-conscience, non-stress-related subthreshold psychotic symptoms are likely to be necessary.
- 1 December 2002
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 32 (6) , 513-518
Eye Movement Abnormality Suggestive of a Spatial Working Memory Deficit Is Present in Parents of Autistic Probands
Autistic probands exhibit impaired spatial accuracy and impaired response suppression errors during a delayed oculomotor response task. Family members of autistic probands, and thus the possible...
- 1 December 2002
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 32 (6) , 513-518
Eye Movement Abnormality Suggestive of a Spatial Working Memory Deficit Is Present in Parents of Autistic Probands
Autistic probands exhibit impaired spatial accuracy and impaired response suppression errors during a delayed oculomotor response task. Family members of autistic probands, and thus the possible...
- 1 November 2002
- Published by Wiley in Psychophysiology
- Vol. 39 (6) , 809-819
Admixture analysis of smooth pursuit eye movements in probands with schizophrenia and their relatives suggests gain and leading saccades are potential endophenotypes
Abnormalities during a smooth pursuit eye movement task (SPEM) are common in schizophrenic patients and their relatives. This study assessed various components of SPEM performance in first‐degree unaffected relatives of schizophrenic patients. One hundred individuals with schizophrenia, 137 unaffected first‐degree relatives, and 69 normal controls completed a 16.7°/s SPEM task. Smooth pursuit gain, catch‐up saccades (CUS), large anticipatory saccades, and leading saccades (LS) were identified. Groups were compared with parametric and admixture analyses. Schizophrenic patients performed more poorly than unaffected relatives and normals on gain, CUS, and LS. Unaffected relatives were more frequently impaired than normals only on gain and LS. Relatives of childhood‐onset and adult‐onset probands had similar impairments. Gain and frequency of leading saccades may be genetic endophenotypes in childhood‐onset and adult‐onset schizophrenia.
- 1 November 2002
- Published by Wiley in Psychophysiology
- Vol. 39 (6) , 809-819
Admixture analysis of smooth pursuit eye movements in probands with schizophrenia and their relatives suggests gain and leading saccades are potential endophenotypes
Abnormalities during a smooth pursuit eye movement task (SPEM) are common in schizophrenic patients and their relatives. This study assessed various components of SPEM performance in first‐degree unaffected relatives of schizophrenic patients. One hundred individuals with schizophrenia, 137 unaffected first‐degree relatives, and 69 normal controls completed a 16.7°/s SPEM task. Smooth pursuit gain, catch‐up saccades (CUS), large anticipatory saccades, and leading saccades (LS) were identified. Groups were compared with parametric and admixture analyses. Schizophrenic patients performed more poorly than unaffected relatives and normals on gain, CUS, and LS. Unaffected relatives were more frequently impaired than normals only on gain and LS. Relatives of childhood‐onset and adult‐onset probands had similar impairments. Gain and frequency of leading saccades may be genetic endophenotypes in childhood‐onset and adult‐onset schizophrenia.
- 1 May 2002
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 41 (5) , 538-545
Childhood-Onset Schizophrenia: Premorbid and Prodromal Diagnostic and Treatment Histories
- 1 May 2002
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 41 (5) , 538-545
Childhood-Onset Schizophrenia: Premorbid and Prodromal Diagnostic and Treatment Histories